Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06191731 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Kinetics of Urinary Excretion of Gadolinium Contrast Agents Used in MRI Examinations

Study acronym: GADODURABLE
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Site details revised at 1 of 2 sitesv6
  2. Primary and study completion dates: Apr 12, 2026 to Apr 12, 2028
    • Study sites: 1 to 2
    v5
  3. Primary and study completion dates: Apr 12, 2025 to Apr 12, 2026
    • Eligibility criteria shortened, about 5 words
    v4
  4. Trial status: Not Yet Recruiting to Recruiting
    • Primary and study completion dates: Mar 1, 2025 to Apr 12, 2025
    • Start date changed from estimate of Mar 1, 2024 to Apr 12, 2024
    • Study site revised
    v3
  5. Start date: Jan 2024 to Mar 1, 2024
    • Primary and study completion dates: Jan 2025 to Mar 1, 2025
    v2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a single-center cohort study aimed to describe the urinary excretion kinetics of gadolinium contrast agents (Gd-CAs). Patients with a prescription for injected MRI are invited to participate in the study. If they agree, blood and urine samples are collected before Gd-CAs injection, and urine samples are collected between 0- and two-and-a-half-hours post-injection of Gd-CAs.
Trial Details
NCT Number NCT06191731
Lead Sponsor Centre Hospitalier Régional Metz-Thionville
Collaborators: University of Lorraine
Conditions
(from sponsor)		 Magnetic Resonance Imaging
Enrollment 60 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov